Connecticut Attorney General William Tong filed a lawsuit against Triggered Brand for selling unapproved 'research grade' GLP-1 weight loss drugs directly to consumers without prescriptions or medical oversight, violating the Connecticut Unfair Trade Practices Act and pharmacy licensing laws. The AG also issued a Civil Investigative Demand to Made In China for similar sales and sent warning letters to weight loss clinics about compounded GLP-1 drugs.
The lawsuit seeks civil penalties of up to $5,000 per violation for selling unapproved drugs without a pharmacy license and engaging in unfair trade practices.
In-house legal teams should review vendor and supplier agreements to ensure partners hold valid pharmacy licenses, only distribute FDA-approved drugs, mandate prescriptions for prescription medications, and prohibit the sale of 'research-grade' or unapproved compounds for human consumption. Contracts should include compliance with state unfair trade practices laws, robust product safety and labeling requirements, and restrictions on deceptive marketing of compounded or counterfeit medications.
Entity
Triggered Brand
Industry
HealthcareOfficial Press Release
https://portal.ct.gov/ag/press-releases/2025-press-releases/attorney-general-tong-sues-glp-1-weight-loss-drug-distributor-triggered-brand
letter to wt loss clinics spas 52125 final.pdf?rev=092249d64
https://portal.ct.gov/-/media/ag/press_releases/2025/letter-to-wt-loss-clinics--spas-52125-final.pdf?rev=092249d64e7944379af755e39def28d2&hash=691621FFBBCB39EF0AC957F4586F2FC0
Connecticut Attorney General Enforcement Page
https://portal.ct.gov/AG/Privacy/Privacy-Resources
"Triggered Brand"
"Connecticut Unfair Trade Practices Act"
"statutes prohibiting the practice of pharmacy without a license"
"sell 'research grade' GLP-1 peptides direct to Connecticut consumers for weight loss without prescriptions or any medical oversight"
$29.6M
Attorney General Jennifer Davenport joined a coalition of 48 states and territories in a $29.6 million settlement with Glenmark, a generic drug manufacturer, for allegedly conspiring to artificially inflate and manipulate prices, reduce competition, and restrain trade for numerous generic prescription drugs. The settlement includes cooperation in ongoing litigations and internal reforms to ensure fair competition.
$29.6M
Attorney General William Tong led a coalition of 48 states and territories in a $29.6 million settlement with Glenmark, a generic drug manufacturer, to resolve allegations of a widespread conspiracy to artificially inflate prices, reduce competition, and unreasonably restrain trade for numerous generic prescription drugs. The settlement includes cooperation from Glenmark in ongoing multistate litigations and internal reforms to ensure fair competition and compliance with antitrust laws.
$18.0M
Attorney General William Tong led a coalition of 42 attorneys general in a settlement with the bankruptcy trustee for 23andMe, resolving allegations from a 2023 data breach that compromised the genetic data of 6.9 million customers. The settlement includes $150 million in allowed claims, with $18 million paid from bankruptcy funds, and requires enhanced data security measures for the new entity holding the data.
Attorney General William Tong joined a coalition of 12 attorneys general in suing to block the $110 billion acquisition of Warner Bros. Discovery, Inc. by Paramount Skydance Corporation. The lawsuit alleges the merger violates Section 7 of the Clayton Act by substantially lessening competition in theatrical film distribution and basic cable television licensing, which would harm consumers through higher prices and reduced quality.
Attorney General William Tong and 48 other attorneys general submitted comments to the FCC urging stronger rules to prevent scammers from accessing legitimate telephone numbers for illegal robocalls. The coalition is responding to the FCC's proposed rules and asks for measures such as stronger certification, reporting, and prohibitions on number cycling.
$45.0M
Attorney General Tong announced a $45 million multistate settlement with Block, Inc., the company behind Cash App, for misleading consumers about the safety of the platform, failing to protect users from fraud, and not providing promised fraud protection and resolution services. The settlement requires Block to implement major reforms including real customer support, transparent communications, and security commitments, and reaffirms Block's commitment to distribute between $75 million and $120 million to compensate consumers as part of a separate CFPB settlement.